Appetite Modulation: CBGâs Role as a Stimulating Cannabinoid
July 30, 2025, 1:37 p.m.
Cannabigerol (CBG) is rapidly emerging in the scientific and wellness communities as a cannabinoid with unique properties, including its role in appetite modulation. Researchers and enthusiasts alike have begun to appreciate the potential of CBG as a stimulating cannabinoid that might influence f.…
Read more
Analgesic Properties of CBG: Pain Management Insights
July 30, 2025, 1:37 p.m.
The exploration of Cannabigerol (CBG) in pain management unveils a promising alternative in the realm of natural analgesics. Recent studies have highlighted its significant analgesic, anti-inflammatory, anti-convulsant, and anxiolytic properties without the psychoactive effects of THC. Early rese.…
Read more
CBG for Anxiety and Depression: Emerging Data
July 30, 2025, 1:36 p.m.
Cannabigerol (CBG) is emerging as an area of significant interest in the cannabis research community, particularly due to its potential benefits for anxiety and depression. Preclinical research and anecdotal evidence have started to shine a light on CBG, placing it alongside more well-known canna.…
Read more
Analytical Methods: Quantifying CBG in Plant Material and Products
July 30, 2025, 1:36 p.m.
Cannabigerol, or CBG, is gaining significant attention in the cannabis space due to its potential therapeutic benefits and its role as the precursor to many other cannabinoids. The process of accurately quantifying CBG in plant material and final products is critical for both research and commerc.…
Read more
Human Pilot Trials of CBG: What We Know So Far
July 30, 2025, 1:36 p.m.
Cannabigerol (CBG) is rapidly emerging as a cannabinoid of interest in the cannabis research community. While many studies have focused on THC and CBD, CBG is now gaining attention as an agent with unique properties that could revolutionize medical cannabis treatment.
Read more
Safety Profile of CBG: Dosing, Side Effects, and Tolerability
July 30, 2025, 1:36 p.m.
Cannabigerol, commonly known as CBG, is emerging as a promising cannabinoid with a unique profile in the cannabis landscape. Researchers and clinicians alike are noting that, unlike its more famous cousins such as THC and CBD, CBG holds potential therapeutic benefits with a particularly favorable.…
Read more
CBGâs Impact on Muscle Spasticity in MS Models
July 30, 2025, 1:36 p.m.
The exploration of cannabinoids in medical research has grown exponentially over the past decade, and CBG, or cannabigerol, is emerging as a promising compound in the field of neurology and multiple sclerosis (MS) management. Recent studies suggest that CBG could play a role in reducing muscle sp.…
Read more
CBG for Glaucoma: Effects on Intraocular Pressure
July 30, 2025, 1:36 p.m.
Cannabigerol (CBG) is rapidly emerging as a promising cannabinoid in the treatment spectrum of various health conditions, including glaucoma. Recent interest in CBG stems from its potential to modulate intraocular pressure (IOP), a key factor in the progression of glaucoma.
Read more
CBG as an Antibacterial Agent: Activity Against MRSA
July 30, 2025, 1:36 p.m.
Cannabigerol (CBG) has emerged as a promising compound in the realm of cannabinoids, with distinctive properties that extend beyond its well-known counterparts like CBD and THC. It is garnering increasing attention for its potential as an antibacterial agent, particularly against Drug-resistant s.…
Read more
